Zafgen is a clinical-stage biopharmaceutical company utilizing its proprietary methionine aminopeptidase 2, or MetAP2, biology platform to develop therapies for patients affected by complex metabolic diseases. The company's primary product candidate is ZGN-1061, a fumagillin-class MetAP2 inhibitor administered by subcutaneous injection, which is being profiled for its utility in the treatment of type 2 diabetes. The company also has initiated development of a second MetAP2 development candidate, ZGN-1258, which is administered by subcutaneous injection.
  • TickerZFGN
  • ISINUS98885E1038
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Kambiz Yazdi ...
  • Liana Moussatos
  • Shveta Dighe

Dropping Coverage Due to Realignment of Analyst Resources

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch